200 related articles for article (PubMed ID: 1617334)
1. Receptor-targeted immunotherapy.
Janson RW; Arend WP
Bull Rheum Dis; 1992; 41(3):6-8. PubMed ID: 1617334
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4.
Quagliata F; Schenkelaars EJ; Ferrone S
Isr J Med Sci; 1993; 29(2-3):154-9. PubMed ID: 8468170
[No Abstract] [Full Text] [Related]
3. The emerging role of biologics in rheumatic disease.
Strand V
J Rheumatol Suppl; 1992 Apr; 33():40-5. PubMed ID: 1593600
[TBL] [Abstract][Full Text] [Related]
4. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
5. [New treatments of rheumatoid arthritis for future use].
Cantagrel A; Mazières B
Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):45S-52S. PubMed ID: 8162008
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor gene therapy for autoimmune diseases.
Fujio K; Okamura T; Okamoto A; Yamamoto K
Ann N Y Acad Sci; 2007 Sep; 1110():222-32. PubMed ID: 17911437
[TBL] [Abstract][Full Text] [Related]
8. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
Fenner H
Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
[TBL] [Abstract][Full Text] [Related]
9. [New immunologic treatment of rheumatoid arthritis].
Sany J
Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors.
Prud'homme GJ
J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913
[TBL] [Abstract][Full Text] [Related]
11. The role of T cells in rheumatoid arthritis: new subsets and new targets.
Toh ML; Miossec P
Curr Opin Rheumatol; 2007 May; 19(3):284-8. PubMed ID: 17414957
[TBL] [Abstract][Full Text] [Related]
12. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.
VanderBorght A; Geusens P; Raus J; Stinissen P
Semin Arthritis Rheum; 2001 Dec; 31(3):160-75. PubMed ID: 11740797
[TBL] [Abstract][Full Text] [Related]
13. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of rheumatic diseases based on understanding genetic predisposition to the development of these diseases.
Fathman CG
Rheum Dis Clin North Am; 1992 Nov; 18(4):915-26. PubMed ID: 1280848
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
[TBL] [Abstract][Full Text] [Related]
16. Regulatory B cells in autoimmune diseases: how do they work?
Lemoine S; Morva A; Youinou P; Jamin C
Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
[TBL] [Abstract][Full Text] [Related]
17. Soluble T cell receptors: novel immunotherapies.
Molloy PE; Sewell AK; Jakobsen BK
Curr Opin Pharmacol; 2005 Aug; 5(4):438-43. PubMed ID: 15939669
[TBL] [Abstract][Full Text] [Related]
18. Oral tolerance in the control of experimental models of autoimmune disease.
Staines NA; Harper N
Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic intervention in autoimmunity.
Tisch R; Yang XD; McDevitt HO
Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
[No Abstract] [Full Text] [Related]
20. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
Wauben MH
Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
